Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

Report Code: BT 3161 May, 2019, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Request For Special Pricing

[210 Pages Report]The global dPCR and qPCR market is highly competitive. The market is estimated to grow to USD 6,270.9 million by 2024 from USD 4,113.3 million in 2019, at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

Digital PCR and Real-time PCR (qPCR) Market

By qPCR and dPCR products and services, theqPCR and dPCR reagents & consumables segment is expected to be the largest segment of the market in 2019

The qPCR reagents & consumables segment is expected to command the largest share of the qPCR products & services market during the forecast period. Factors such as the expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR reagents and consumables market.

The dPCR reagents and consumables segment is expected to account for the largest share of the dPCR products and services market in 2019. This segment includes specific reagents (such as master mixes, assay kits, and enzymes) and consumables (such as reaction tubes, needles, and vials) used during dPCR procedures. Generally, dPCR reagents consist of a super mix or a master mix that contains the buffer, DNA polymerase, dNTPs, and dsDNA-binding dyes.

By qPCR and dPCR application, the clinical application segment is estimated to dominate the qPCR applications during the forecast period

The clinical applications segment is estimated to dominate the qPCR applications market during the forecast period. The key factors driving the market growth include the growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment.

The clinical applications segment is expected to account for the dPCR market in 2019. The technological benefits offered by dPCR over qPCR & traditional PCR (such as high flexibility, increased device sensitivity, better precision, and absolute quantification of target molecule), the growing adoption of dPCR among hospitals & diagnostic centers, and increasing global burden of cancer & AIDS are key factors that will drive the market for clinical applications during the study period.

Digital PCR and Real-time PCR (qPCR) Market

Digital PCR and Real-time PCR (qPCR) Market

North America dominated the market in 2019

In 2019, North America is expected to dominate the qPCR and dPCR market, followed by Europe. Growth in the North American qPCR and dPCR market will be propelled by increased adoption of innovative and novel genomic analysis products (including advanced qPCR and dPCR products), availability of R&D funding for genomic research (coupled with the robust research infrastructure in the region), expanding use of PCR techniques in clinical diagnostics & forensics, and early commercialization of qPCR/dPCR products compared to other regions.

Digital PCR and Real-time PCR (qPCR) Market

Market Dynamics

The growth of the dPCR and qPCR market is primarily driven by the rising incidences of infectious diseases and genetic disorders, which have driven the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the market and ensured strong support in the form of investments, funds, and grants. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

Driver: Rising incidences of target infectious diseases and genetic disorders

The demand for genomic analysis techniques has grown steadily during the last decade on the back of their increasing use (microbial identification and detection of genetic mutations) in the diagnosis of major infectious diseases (such as HIV, tuberculosis, malaria, hepatitis, and Staph-related diseases) and genetic disorders (such as cancer and syndromes). Growth in the prevalence of target diseases globally, coupled with the proven efficacy of qPCR and dPCR analysis in the diagnosis and estimation of disease-causing microbes, will boost the use of clinical diagnostic tests (including qPCR and dPCR analysis) and support market growth. In this regard:

  • According to UNAIDS Data, approximately 36.9 million people were suffering from HIV-AIDS globally, as of 2017, with an average mortality of 0.9 million. Of these, 1.8 million new HIV infection cases were reported in 2017 alone.
  • In 2017, ~6.4 million new TB cases were registered across the world (WHO data, 2019).
  • Approximately 219 million patients were suffering from malaria globally, as of 2018, with 92% cases registered in WHO Africa alone (Source: WHO data, 2019).

Restraint: High device costs associated with dPCR

A typical PCR analysis conducted through dPCR instruments involves several scientific technologies (PCR, microfluidics, and nanofabrication) integrated to achieve the desired process outcome. These instruments are small and boast reduced cycle times. However, the development of such instruments requires large capital investments and extensive scientific validation on a nanoscale level. Moreover, dPCR is a relatively new technology; as a result, most manufacturers often price their state-of-art dPCR instruments at a premium (~USD 120,000) compared to qPCR instruments (~USD 50,000). For instance, as of January 2016, the average price of a dPCR instrument is reported to be USD 55,000–120,000, according to their device architecture and target application area in the US. Such high prices have resulted in the subdued adoption of dPCR instruments among price-sensitive end users.

Additionally, the demand for premium-priced dPCR instruments and reagents is restricted due to the end-user preference for cheaper genomic techniques (such as gel electrophoresis and traditional PCR), especially among researchers and small CROs and pharmaceutical & biotechnology companies.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017-2024

Base Year Considered

2018

Forecast Period

2019–2024

Forecast Units

Value (USD)

Segments Covered

Products and service, application, end user, and region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLA) and Middle East & Africa

Companies Covered

F. Hoffman-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), Biomιrieux S.A., Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Becton Dickinson and Company (US), Promega Corporation (US), Eppendorf AG (Germany), Analytik Jena AG (Germany), Meridian Bioscience, Inc. (US), Enzo Life Sciences, Inc. (US), Cole-Parmer Instrument Company Llc (US), Bioneer Corporation (South Korea), Elitech Group Sas (France), Quanta Biosciences Inc. (US), Sacace Biotechnologies Srl (Italy), Bio Molecular Systems (Australia), Biomeme Inc. (US), and JN Medsys (Singapore).

This report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market into the following segments and subsegments:

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, by Products & Services

  • qPCR
    • Instruments
    • Reagents & Consumables
    • Software & Services
  • dPCR
    • Instruments
    • Reagents & Consumables
    • Software & Services

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, by Application

  • qPCR
    • Clinical
  • Infectious Diseases Testing
  • Oncology Testing
  • Blood Screening
  • Transplant Diagnostics
  • Other Clinical Applications
    • Research
    • Forensic
  • dPCR
    • Clinical
  • Infectious Diseases Testing
  • Oncology Testing
  • Blood Screening
  • Transplant Diagnostics
  • Other Clinical Applications
    • Research
    • Forensic

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, By End User

  • qPCR
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories
  • dPCR
    • Hospitals and Diagnostic Centers
    • Research Laboratories and Academic Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East & Africa

Key Market Players

As of 2016, the global dPCR market was dominated by Bio-Rad Laboratories Inc. (US), Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands).

Bio-Rad Laboratories Inc. (US) is one of the leading players in the field of disease diagnostics & laboratory products. The company has a noteworthy presence in the dPCR and qPCR industry and a wide geographic presence in major markets (such as the US, Germany, Japan, China, India, and Brazil). Bio-Rad is involved in the development, manufacturing, and marketing of more than 5,000 reagents, apparatuses, and laboratory instruments (including qPCR and dPCR products). The acquisition of RainDance Technologies in 2017, enabled Bio-Rad to strengthen its position in the dPCR market, thereby leveraging RainDance’s droplet micro fluid technology for novel product development and product portfolio expansion.

Thermo Fisher Scientific (US) is one of the leading players in the field of healthcare and life science research. The company possesses a robust product portfolio in the dPCR and qPCR segment and a strong market presence globally, with sales and distribution networks in more than 50 countries. It focuses on strengthening its market position in the flow cytometry market by adopting various growth strategies (such as product launches & approvals, acquisitions, and partnerships). The company mainly focuses on business strategies that include launching new products and gaining approvals in order to expand its product portfolio and offer its customers with a wide range of dPCR and qPCR products. In line with this strategy, Thermo Fisher Scientific also launched several products including the SureTect Cronobacter Species Real-Time PCR Assay (2016), Axiom Africa Array (2017), QuantStudio 5 Real-Time PCR System (2017), and TaqMan Digital PCR Liquid Biopsy Assays (2017) and it also received regulatory approvals for TaqPath Zika Virus Kit (2017), QuantStudio 5 Dx Real-Time PCR System (2017), and RapidFinder Salmonella Multiplex PCR Workflow (2018) from respective authorities.

Recent Developments:

  • In 2019, Bio-Rad received the US FDA’s approval for QXDx AutoDG ddPCR System and the QXDx BCR-ABL %IS Kit
  • In 2019, Qiagen, announced the development of a range of next-generation systems for digital PCR, in the life sciences industry.
  • In 2019, Abbott entered into an eight-year partnership agreement with Japanese Red Cross Society (JRC). Under this agreement, Abbott will be an exclusive supplier to JRC for serological instrumentation, tests, and consumables used for blood and plasma screening in Japan. This development helps Abbott strengthen its position and increase its revenue base in the Japanese market.
  • In 2018, Agilent Technologies, Inc. acquired Young In Scientific Co. Ltd. of South Korea. This acquisition helped Agilent strengthen and expand its presence in the South Korean and Asian market.
  • In 2017, Eppendorf India (a wholly owned subsidiary of Eppendorf AG), expanded its training center at its facility located in Chennai (India). This center will offer tailor-made training programs for biotechnology students, faculties, and researchers in the country. This development has significantly helped the company in strengthening its brand position in the Indian market.

Key questions addressed in the report:

  • What are the growth opportunities related to qPCR and dPCR market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of qPCR and dPCR. Will this scenario continue in the next five years?
  • What are the various types of qPCR and dPCR instruments, reagents, software & services and their market share in the overall market?
  • What are the new trends and advancements in the reagents & consumables segment of qPCR and dPCR market?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
           1.3.1 Years Considered for the Study
    1.4 Currency Used
    1.5 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Methodology Steps
    2.2 Secondary Research
    2.3 Primary Research
    2.4 Market Estimation Methodology
           2.4.1 Revenue Mapping-Based Market Estimation
           2.4.2 Usage-Based Market Estimation
           2.4.3 Primary Research Validation
    2.5 Market Breakdown & Data Triangulation
    2.6 Research Assumptions
    2.7 Research Limitations

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 39)

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Rising Incidences of Target Infectious Diseases and Genetic Disorders
                    5.2.1.2 Continuous Technological Advancements in Pcr Technologies
                    5.2.1.3 Increasing Investments, Funds, and Grants
                    5.2.1.4 Increasing use of Biomarker Profiling for Disease Diagnostics
                    5.2.1.5 Successful Completion of the Human Genome Project
           5.2.2 Key Market Restraints
                    5.2.2.1 High Device Costs Associated With dPCR
                    5.2.2.2 Technical Limitations of qPCR and dPCR Techniques
           5.2.3 Key Market Opportunities
                    5.2.3.1 Growing Market Penetration in Emerging Countries
                    5.2.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
           5.2.4 Key Market Challenges
                    5.2.4.1 Adoption and Implementation of Miqe Guidelines
           5.2.5 Key Market Trends
                    5.2.5.1 Development of Compact, Portable, and Lab-On-Chip Pcr Devices
                    5.2.5.2 Ongoing Technological Integration With the Pcr Process

6 dPCR and qPCR Market, By Product & Service (Page No. - 53)
    6.1 Introduction
    6.2 qPCR Products & Services
           6.2.1 qPCR Reagents and Consumables
                    6.2.1.1 Global qPCR Reagents and Consumables Market, By Application
                    6.2.1.2 Global qPCR Reagents and Consumables Market, By End User
           6.2.2 qPCR Instruments
                    6.2.2.1 Global qPCR Instruments Market, By Application
                    6.2.2.2 Global qPCR Instruments Market, By End User
           6.2.3 qPCR Software and Services
                    6.2.3.1 Global qPCR Software and Services Market, By Application
                    6.2.3.2 Global qPCR Software and Services Market, By End User
    6.3 dPCR Products & Services
           6.3.1 dPCR Instruments
                    6.3.1.1 Global dPCR Instruments Market, By Application
                    6.3.1.2 Global dPCR Instruments Market, By End User
           6.3.2 dPCR Reagents and Consumables
                    6.3.2.1 Global dPCR Reagents and Consumables Market, By Application
                    6.3.2.2 Global dPCR Reagents and Consumables Market, By End User
           6.3.3 dPCR Software and Services
                    6.3.3.1 Global dPCR Software and Services Market, By Application
                    6.3.3.2 Global dPCR Software and Services Market, By End User

7 dPCR and qPCR Market, By Application (Page No. - 71)
    7.1 Introduction
    7.2 qPCR Applications
           7.2.1 Clinical Applications
                    7.2.1.1 Infectious Disease Testing
                               7.2.1.1.1 the Wide Availability of qPCR Assays and Kits for Infectious Disease Testing is a Key Factor Driving Market Growth
                    7.2.1.2 Oncology Testing
                               7.2.1.2.1 Advent of Alternative Diagnostic Technologies for Oncology Testing to the Key Restraining Factor
                    7.2.1.3 Blood Screening
                               7.2.1.3.1 the Advantages Offered By qPCR Such as the Elimination of Post-Amplification Processing and Easy Process Automation to Drive the Demand for qPCR Products
                    7.2.1.4 Transplant Diagnostics
                               7.2.1.4.1 Increasing Commercialization of qPCR Products for Transplant Diagnostic to Drive the Market Growth
                    7.2.1.5 Other Clinical Applications
           7.2.2 Research Applications
                    7.2.2.1 Increase in Genome-Based Research Activity Boosts the Market Growth
           7.2.3 Forensic Applications
                    7.2.3.1 Limited Adoption of qPCR in Underdeveloped and Developing Countries is Expected to Restrict the Market Growth
    7.3 dPCR Applications
           7.3.1 Clinical Applications
                    7.3.1.1 Infectious Disease Testing
                               7.3.1.1.1 Accuracy and Precision of dPCR Have Made It a Prominent Tool in Infectious Disease Testing
                    7.3.1.2 Oncology Testing
                               7.3.1.2.1 dPCR Plays a Vital Role in Oncology Testing and Clinical Studies
                    7.3.1.3 Blood Screening
                               7.3.1.3.1 dPCR Offers Multiple Advantages Over Traditional Techniques for Blood Screening
                    7.3.1.4 Transplant Diagnostics
                               7.3.1.4.1 Low Market Availability of dPCR Products for Transplant Diagnostics to Reflect in Small Share of This Market Segment
                    7.3.1.5 Other Clinical Applications
           7.3.2 Research Applications
                    7.3.2.1 Wide Usage of dPCR in Genetic Research is the Primary Driver for Market Growth
           7.3.3 Forensic Applications
                    7.3.3.1 the Need to Reduce the Time and Cost of Forensic Processes is a Key Factor Driving Market Growth

8 dPCR and qPCR Market, By End User (Page No. - 90)
    8.1 Introduction
    8.2 qPCR End Users
           8.2.1 Hospitals and Diagnostic Centers
           8.2.2 Research Laboratories and Academic Institutes
           8.2.3 Pharmaceutical and Biotechnology Companies
           8.2.4 Clinical Research Organizations
           8.2.5 Forensic Laboratories
    8.3 dPCR End Users
           8.3.1 Hospitals and Diagnostic Centers
           8.3.2 Research Laboratories and Academic Institutes
           8.3.3 Pharmaceutical and Biotechnology Companies
           8.3.4 Clinical Research Organizations
           8.3.5 Forensic Laboratories

9 dPCR and qPCR Market, By Region (Page No. - 105)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US to Dominate the North American dPCR and qPCR Market in 2019
           9.2.2 Canada
                    9.2.2.1 Government Initiatives for Supporting Genomics Research to Drive Market Growth in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Germany to Dominate the European dPCR and qPCR Market
           9.3.2 UK
                    9.3.2.1 Growing Focus on Genomics Research to Support Market Growth in the UK
           9.3.3 France
                    9.3.3.1 Initiatives for Developing Genomic Medicine to Support Market Growth in France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Strong Research and Healthcare Infrastructure to Support Market Growth in Japan
           9.4.2 China
                    9.4.2.1 Healthcare Infrastructure Modernization to Support Market Growth in China
           9.4.3 India
                    9.4.3.1 Presence of a Large Target Patient Population to Support Market Growth in India
           9.4.4 Australia
           9.4.5 South Korea
           9.4.6 Rest of APAC
    9.5 Latin America
           9.5.1 Brazil
                    9.5.1.1 Brazil Dominated the Latam Market in 2018
           9.5.2 Mexico
                    9.5.2.1 Favorable Trade Agreements Will Support Imports and Improve the Accessibility to dPCR and qPCR Instruments in Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East and Africa
           9.6.1 Low Purchasing Power of End Users and Infrastructural Limitations to Restrain Market Growth in the MEA

10 Competitive Landscape (Page No. - 145)
     10.1 Overview
     10.2 Global Market Share Analysis
             10.2.1 Global qPCR Market Share Analysis (2018)
             10.2.2 Global dPCR Market Share Analysis (2018)
     10.3 Competitive Scenario
             10.3.1 Key Product Launches, Enhancements, and Approvals (2016–2019)
             10.3.2 Key Partnerships and Collaborations (2016–2019)
             10.3.3 Key Acquisitions (2016–2019)
             10.3.4 Key Expansions (2016–2019)
     10.4 Competitive Leadership Mapping
             10.4.1 Competitive Leadership Mapping: Major Market Players (2018)
                       10.4.1.1 Visionary Leaders
                       10.4.1.2 Innovators
                       10.4.1.3 Dynamic Differentiators
                       10.4.1.4 Emerging Companies
             10.4.2 Competitive Leadership Mapping: Emerging Companies/SMES/Start-Ups (2018)
                       10.4.2.1 Progressive Companies
                       10.4.2.2 Starting Blocks
                       10.4.2.3 Responsive Companies
                       10.4.2.4 Dynamic Companies

11 Company Profiles (Page No. - 155)
     11.1 Abbott Laboratories
             11.1.1 Business Overview
             11.1.2 Products Offered
             11.1.3 Recent Developments (2016-2019)
     11.2 Agilent Technologies, Inc.
             11.2.1 Business Overview
             11.2.2 Products and Services Offered
             11.2.3 Recent Developments (2016-2019)
     11.3 Analytik Jena AG (A Wholly Owned Subsidiary of Endress+Hauser AG)
             11.3.1 Business Overview
             11.3.2 Products and Services Offered
             11.3.3 Recent Developments (2016-2019)
     11.4 Becton Dickinson and Company
             11.4.1 Business Overview
             11.4.2 Products and Services Offered
             11.4.3 Recent Developments (2016-2019)
     11.5 bioMιrieux S.A.
             11.5.1 Business Overview
             11.5.2 Products and Services Offered
             11.5.3 Recent Developments (2016-2019)
     11.6 Bio-Rad Laboratories, Inc.
             11.6.1 Business Overview
             11.6.2 Products and Services Offered
             11.6.3 Recent Developments (2016-2019)
             11.6.4 MnM View
     11.7 Danaher Corporation
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments (2016-2019)
     11.8 Eppendorf AG
             11.8.1 Business Overview
             11.8.2 Products Offered
             11.8.3 Recent Developments (2016-2019)
     11.9 F. Hoffman-La Roche Ltd.
             11.9.1 Business Overview
             11.9.2 Products and Services Offered
             11.9.3 Recent Developments (2016-2019)
     11.10 Fluidigm Corporation
               11.10.1 Business Overview
               11.10.2 Products Offered
               11.10.3 Recent Developments (2016-2019)
     11.11 Merck KGaA
               11.11.1 Business Overview
               11.11.2 Products and Services Offered
               11.11.3 Recent Developments (2016-2019)
     11.12 Promega Corporation
               11.12.1 Business Overview
               11.12.2 Products and Services Offered
               11.12.3 Recent Developments (2016-2019)
     11.13 QIAGEN N.V.
               11.13.1 Business Overview
               11.13.2 Products Offered
               11.13.3 Recent Developments (2016-2019)
     11.14 Takara Bio, Inc.
               11.14.1 Business Overview
               11.14.2 Products and Services Offered
               11.14.3 Recent Developments (2016-2019)
     11.15 Thermo Fisher Scientific, Inc.
               11.15.1 Business Overview
               11.15.2 Products and Services Offered
               11.15.3 Recent Developments (2016-2019)
               11.15.4 MnM View

12 Appendix (Page No. - 202)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (120 Tables)

Table 1 Global dPCR and qPCR Market, By Technology, 2017–2024 (USD Million)
Table 2 Global qPCR Products & Services Market, By Type, 2017–2024 (USD Million)
Table 3 qPCR Products & Services Market, By Region, 2017–2024 (USD Million)
Table 4 qPCR Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 5 Global qPCR Reagents and Consumables Market, By Application, 2017–2024 (USD Million)
Table 6 Global qPCR Reagents and Consumables Market, By End User, 2017–2024 (USD Million)
Table 7 qPCR Instruments Market, By Region, 2017–2024 (USD Million)
Table 8 Global qPCR Instruments Market, By Application, 2017–2024 (USD Million)
Table 9 Global qPCR Instruments Market, By End User, 2017–2024 (USD Million)
Table 10 qPCR Software and Services Market, By Region, 2017–2024 (USD Million)
Table 11 Global qPCR Software and Services Market, By Application, 2017–2024 (USD Million)
Table 12 Global qPCR Software and Services Market, By End User, 2017–2024 (USD Million)
Table 13 Global dPCR Products & Services Market, By Type, 2017–2024 (USD Million)
Table 14 dPCR Products & Services Market, By Region, 2017–2024 (USD Million)
Table 15 dPCR Instruments Market, By Region, 2017–2024 (USD Million)
Table 16 Global dPCR Instruments Market, By Application, 2017–2024 (USD Million)
Table 17 Global dPCR Instruments Market, By End User, 2017–2024 (USD Million)
Table 18 dPCR Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 19 Global dPCR Reagents and Consumables Market, By Application, 2017–2024 (USD Million)
Table 20 Global dPCR Reagents and Consumables Market, By End User, 2017–2024 (USD Million)
Table 21 dPCR Software and Services Market, By Region, 2017–2024 (USD Million)
Table 22 Global dPCR Software and Services Market, By Application, 2017–2024 (USD Million)
Table 23 Global dPCR Software and Services Market, By End User, 2017–2024 (USD Million)
Table 24 Global qPCR Market, By Application, 2017–2024 (USD Million)
Table 25 Global qPCR Clinical Applications Market, By Type, 2017–2024 (USD Million)
Table 26 qPCR Clinical Applications Market, By Region, 2017–2024 (USD Million)
Table 27 qPCR Clinical Applications Market for Infectious Disease Testing, By Region, 2017–2024 (USD Million)
Table 28 qPCR Clinical Applications Market for Oncology Testing, By Region, 2017–2024 (USD Million)
Table 29 qPCR Clinical Applications Market for Blood Screening, By Region, 2017–2024 (USD Million)
Table 30 qPCR Clinical Applications Market for Transplant Diagnostics, By Region, 2017–2024 (USD Million)
Table 31 qPCR Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 32 qPCR Research Applications Market, By Region, 2017–2024 (USD Million)
Table 33 qPCR Forensic Applications Market, By Region, 2017–2024 (USD Million)
Table 34 Global dPCR Market, By Application, 2017–2024 (USD Million)
Table 35 Global dPCR Clinical Applications Market, By Type, 2017–2024 (USD Million)
Table 36 dPCR Clinical Applications Market, By Region, 2017–2024 (USD Million)
Table 37 dPCR Clinical Applications Market for Infectious Disease Testing, By Region, 2017–2024 (USD Million)
Table 38 dPCR Clinical Applications Market for Oncology Testing, By Region, 2017–2024 (USD Million)
Table 39 dPCR Clinical Applications Market for Blood Screening, By Region, 2017–2024 (USD Million)
Table 40 dPCR Clinical Applications Market for Transplant Diagnostics, By Region, 2017–2024 (USD Million)
Table 41 dPCR Market for Other Clinical Applications, By Region, 2017–2024 (USD Million)
Table 42 dPCR Research Applications Market, By Region, 2017–2024 (USD Million)
Table 43 dPCR Forensic Applications Market, By Region, 2017–2024 (USD Million)
Table 44 Global qPCR Market, By End User, 2017–2024 (USD Million)
Table 45 qPCR Market for Hospitals and Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 46 qPCR Market for Research Laboratories and Academic Institutes, By Region, 2017–2024 (USD Million)
Table 47 qPCR Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 48 qPCR Market for Clinical Research Organizations, By Region, 2017–2024 (USD Million)
Table 49 qPCR Market for Forensic Laboratories, By Region, 2017–2024 (USD Million)
Table 50 Global dPCR Market, By End User, 2017–2024 (USD Million)
Table 51 dPCR Market for Hospitals and Diagnostic Centers, By Region, 2017–2024 (USD Million)
Table 52 dPCR Market for Research Laboratories and Academic Institutes, By Region, 2017–2024 (USD Million)
Table 53 dPCR Market for Pharmaceutical and Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 54 dPCR Market for Clinical Research Organizations, By Region, 2017–2024 (USD Million)
Table 55 dPCR Market for Forensic Laboratories, By Region, 2017–2024 (USD Million)
Table 56 dPCR and qPCR Market, By Region, 2017–2024 (USD Million)
Table 57 North America: qPCR Market, By Country, 2017–2024 (USD Million)
Table 58 North America: dPCR Market, By Country, 2017–2024 (USD Million)
Table 59 North America: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 60 North America: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 61 North America: qPCR Market, By Application, 2017–2024 (USD Million)
Table 62 North America: dPCR Market, By Application, 2017–2024 (USD Million)
Table 63 North America: qPCR Market, By End User, 2017–2024 (USD Million)
Table 64 North America: dPCR Market, By End User, 2017–2024 (USD Million)
Table 65 US: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 66 US: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 67 Canada: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 68 Canada: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Europe: qPCR Market, By Country, 2017–2024 (USD Million)
Table 70 Europe: dPCR Market, By Country, 2017–2024 (USD Million)
Table 71 Europe: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 72 Europe: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 73 Europe: qPCR Market, By Application, 2017–2024 (USD Million)
Table 74 Europe: dPCR Market, By Application, 2017–2024 (USD Million)
Table 75 Europe: qPCR Market, By End User, 2017–2024 (USD Million)
Table 76 Europe: dPCR Market, By End User, 2017–2024 (USD Million)
Table 77 Germany: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 78 Germany: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 79 UK: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 80 UK: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 81 France: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 82 France: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 83 RoE: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 84 RoE: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 85 APAC: qPCR Market, By Country, 2017–2024 (USD Million)
Table 86 APAC: dPCR Market, By Country, 2017–2024 (USD Million)
Table 87 Asia Pacific: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 88 Asia Pacific: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 89 Asia Pacific: qPCR Market, By Application, 2017–2024 (USD Million)
Table 90 Asia Pacific: dPCR Market, By Application, 2017–2024 (USD Million)
Table 91 Asia Pacific: qPCR Market, By End User, 2017–2024 (USD Million)
Table 92 Asia Pacific: dPCR Market, By End User, 2017–2024 (USD Million)
Table 93 Japan: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 94 Japan: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 95 China: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 96 China: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 97 India: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 98 India: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 99 RoAPAC: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 100 RoAPAC: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 101 Latin America: qPCR Market, By Country, 2017–2024 (USD Million)
Table 102 Latin America: dPCR Market, By Country, 2017–2024 (USD Million)
Table 103 Latin America: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 104 Latin America: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 105 Latin America: qPCR Market, By Application, 2017–2024 (USD Million)
Table 106 Latin America: dPCR Market, By Application, 2017–2024 (USD Million)
Table 107 Latin America: qPCR Market, By End User, 2017–2024 (USD Million)
Table 108 Latin America: dPCR Market, By End User, 2017–2024 (USD Million)
Table 109 Brazil: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 110 Brazil: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 111 Mexico: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 112 Mexico: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 113 RoLATAM: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 114 RoLATAM: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 115 Middle East and Africa: qPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 116 Middle East and Africa: dPCR Market, By Product & Service, 2017–2024 (USD Million)
Table 117 Middle East and Africa: qPCR Market, By Application, 2017–2024 (USD Million)
Table 118 Middle East and Africa: dPCR Market, By Application, 2017–2024 (USD Million)
Table 119 Middle East and Africa: qPCR Market, By End User, 2017–2024 (USD Million)
Table 120 Middle East and Africa: dPCR Market, By End User, 2017–2024 (USD Million)
 
 
List of Figures (43 Figures)
 
Figure 1 Research Design
Figure 2 Research Methodology: Hypothesis Building
Figure 3 Market Size Estimation Methodology: Global dPCR and qPCR Market
Figure 4 Data Triangulation
Figure 5 Global qPCR Products & Services Market, By Type, 2019 Vs. 2024
Figure 6 Global dPCR Products & Services Market, By Type, 2019 Vs. 2024
Figure 7 Global qPCR Market, By Application, 2019 Vs. 2024
Figure 8 Global dPCR Market, By Application, 2019 Vs. 2024
Figure 9 APAC is Expected to Grow at the Highest Rate During the Forecast Period
Figure 10 Rising Incidences of Target Infectious Diseases and Genetic Disorders is Expected to Drive Market Growth
Figure 11 North America is Expected to Dominate Both qPCR and dPCR Markets During the Forecast Period
Figure 12 Reagents and Consumables to Hold the Largest Share in the Global dPCR and qPCR Markets in 2019
Figure 13 Infectious Disease Testing to be the Fastest Growing Application in qPCR Market During Forecast Period
Figure 14 Asia Pacific to Witness Highest Growth During the Forecast Period
Figure 15 Drivers, Restraints, Opportunities, and Challenges
Figure 16 Global Burden of HIV Infections, By Region, 2017
Figure 17 Growing Geriatric Population Across Key Geographies (2017 Vs. 2030)
Figure 18 Traditional PCR Vs. qPCR and dPCR: a Comparative Study
Figure 19 Reagents and Consumables Segment to Dominate the qPCR Products & Services Market During the Forecast Period
Figure 20 Instruments Segment to Witness the Highest Growth in the dPCR Products & Services Market During the Forecast Period
Figure 21 North America: dPCR and qPCR Market Snapshot
Figure 22 Europe: dPCR and qPCR Market Snapshot
Figure 23 Asia Pacific: dPCR and qPCR Market Snapshot
Figure 24 Latin America: dPCR and qPCR Market Snapshot
Figure 25 Key Developments By Leading Market Players in the dPCR and qPCR Market, 2016–2019
Figure 26 Global qPCR Market Share Analysis, By Key Player (2018)
Figure 27 Global dPCR Market Share Analysis, By Key Player (2016)
Figure 28 Global Competitive Leadership Mapping (Overall Market)
Figure 29 Competitive Leadership Mapping (SME/Start-Ups)
Figure 30 Abbott Laboratories: Company Snapshot (2018)
Figure 31 Agilent Technologies, Inc.: Company Snapshot (2018)
Figure 32 Endress+Hauser AG: Company Snapshot (2017)
Figure 33 Becton Dickinson and Company: Company Snapshot (2018)
Figure 34 bioMιrieux S.A.: Company Snapshot (2018)
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot (2018)
Figure 36 Danaher Corporation: Company Snapshot (2018)
Figure 37 Eppendorf AG: Company Snapshot (2017)
Figure 38 Roche Diagnostic Division: Company Snapshot (2018)
Figure 39 Fluidigm Corporation: Company Snapshot (2018)
Figure 40 Merck KGaA: Company Snapshot (2018)
Figure 41 QIAGEN N.V.: Company Snapshot (2018)
Figure 42 Takara Bio, Inc.: Company Snapshot (2018)
Figure 43 Thermo Fisher Scientific Inc.: Company Snapshot (2018)

The study involved four major activities in estimating the current size of the digital PCR (dPCR) and real-time PCR (qPCR) market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the dPCR and qPCR market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (healthcare providers, research institutes, and healthcare professionals) and supply sides (developers, manufacturers, and distributors of dPCR and qPCR products). The primaries interviewed for this study include experts from the dPCR and qPCR products industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering dPCR and qPCR products and services across the globe) and administrators & purchase managers of hospitals CROs, research institutes, academia, and pharma and biotech companies.

The following is a breakdown of primary respondents:

Digital PCR and Real-time PCR (qPCR) Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

A detailed market estimation approach was followed to estimate and validate the size of the dPCR and qPCR market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the dPCR and qPCR market. All possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size of the dPCR and qPCR industry from the market estimation approach explained above, the global market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact market value data, data triangulation and market breakdown methodology methods were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply side.

Report Objectives

  • To define, describe, and forecast the global dPCR and qPCR market on the basis of product & service, application, and end user
  • To provide detailed information on the major factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall dPCR and qPCR market
  • To analyze opportunities in the global dPCR and qPCR market for major stakeholders and detail the competitive landscape for market leaders
  • To forecast the size of market segments with respect to the five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To profile key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product developments; mergers & acquisitions; expansions; and partnerships, collaborations, & agreements

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global dPCR and qPCR market report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Report Code
BT 3161
Published ON
May, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home